Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open Label Randomized Controlled Trial to Assess the Impact of Prophylactic Exposure to Tenofovir Gel on the Efficacy of Subsequent Tenofovir-containing Antiretroviral Therapy on Viral Suppression

NCT01387022 is registered in ClinicalTrials.gov with Centre for the AIDS Programme of Research in South Africa as lead sponsor.

NCT NCT01387022
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01387022 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open Label Randomized Controlled Trial to Assess the Impact of Prophylactic Exposure to Tenofovir Gel on the Efficacy of Subsequent Tenofovir-containing Antiretroviral Therapy on Viral Suppression
Lead sponsor
Centre for the AIDS Programme of Research in South Africa
Phase
Not applicable
Overall status
Completed
Start date
June 30, 2011
Completion date
November 30, 2014
Enrollment
59 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

antiretroviral treatment outcomes